Article

Targeted isolation of panels of diverse human protective broadly neutralizing antibodies against SARS-like viruses

2021-09-08

Abstract excerpt

<h4>SUMMARY</h4> The emergence of current SARS-CoV-2 variants of concern (VOCs) and potential future spillovers of SARS-like coronaviruses into humans pose a major threat to human health and the global economy 1–7 . Development of broadly effective coronavirus vaccines that can mitigate these threats is needed 8, 9 . Notably, several recent studies have revealed that vaccination of recovered COVID-19 donors res...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f2f4a4fa-5868-5e2d-a57d-1e5df8620fc2
DOI: 10.1101/2021.09.08.459480

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Targeted isolation of panels of diverse human protective broadly neutralizing antibodies against SARS-like virusesDOI 10.1101/2021.09.08.459480Read

Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerabilitySemantic proximity Read

Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe diseaseSemantic proximity Read

A broadly neutralizing antibody recognizing a unique epitope with signature motif common across coronaviral familiesSemantic proximity Read

An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19Semantic proximity Read

Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecovirusesSemantic proximity Read

Structural basis for broad sarbecovirus neutralization by a human monoclonal antibodySemantic proximity Read

A broad and potent neutralization epitope in SARS-related coronavirusesSemantic proximity Read

Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patientsSemantic proximity Read

Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infectionSemantic proximity Read

Engineered receptor binding domain immunogens elicit pan-sarbecovirus neutralizing antibodies outside the receptor binding motifSemantic proximity Read

Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2Semantic proximity Read

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodiesSemantic proximity Read